Jacobs John C

Jacobs John C is listed in filings as President and CEO at Novavax, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including 15 public disclosures. Recent filings connect the profile to Novavax, Inc. (NVAX). The current snapshot covers public activity from Jan 27, 2025 to Mar 9, 2026. Reported amounts are shown as $371.2K to $5.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.